These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 20306761)

  • 1. Evidence-based medicine: four fundamental problems with the randomized clinical trial (RCT) used to document chemical medicine.
    Ventegodt S; Andersen NJ; Brom B; Merrick J; Greydanus DE
    Int J Adolesc Med Health; 2009; 21(4):485-96. PubMed ID: 20306761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indirect comparisons of competing interventions.
    Glenny AM; Altman DG; Song F; Sakarovitch C; Deeks JJ; D'Amico R; Bradburn M; Eastwood AJ;
    Health Technol Assess; 2005 Jul; 9(26):1-134, iii-iv. PubMed ID: 16014203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placebos used in clinical trials for Chinese herbal medicine.
    Qi GD; We DA; Chung LP; Fai CK
    Recent Pat Inflamm Allergy Drug Discov; 2008 Jun; 2(2):123-7. PubMed ID: 19076001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participant expectancies in double-blind randomized placebo-controlled trials: potential limitations to trial validity.
    Colagiuri B
    Clin Trials; 2010 Jun; 7(3):246-55. PubMed ID: 20421243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The randomized controlled trial: gold standard, or merely standard?
    Grossman J; Mackenzie FJ
    Perspect Biol Med; 2005; 48(4):516-34. PubMed ID: 16227664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The double-blind, randomized, placebo-controlled trial: gold standard or golden calf?
    Kaptchuk TJ
    J Clin Epidemiol; 2001 Jun; 54(6):541-9. PubMed ID: 11377113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Entanglement, knowledge, and their possible effects on the outcomes of blinded trials of homeopathic provings.
    Milgrom LR
    J Altern Complement Med; 2006 Apr; 12(3):271-9. PubMed ID: 16646726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Group analysis versus individual response: the inferential limits of randomized controlled trials.
    Kelley JM; Kaptchuk TJ
    Contemp Clin Trials; 2010 Sep; 31(5):423-8. PubMed ID: 20624483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisiting the level of evidence in randomized controlled clinical trials: A simulation approach.
    Bajard A; Chabaud S; Pérol D; Boissel JP; Nony P
    Contemp Clin Trials; 2009 Sep; 30(5):400-10. PubMed ID: 19576298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practising evidence-based medicine in an era of high placebo response: number needed to treat reconsidered.
    Roose SP; Rutherford BR; Wall MM; Thase ME
    Br J Psychiatry; 2016 May; 208(5):416-20. PubMed ID: 27143006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placebo preparation for the proper clinical trial of herbal medicine--requirements, verification and quality control.
    Fai CK; Qi GD; Wei DA; Chung LP
    Recent Pat Inflamm Allergy Drug Discov; 2011 May; 5(2):169-74. PubMed ID: 21457134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The placebo is powerful: estimating placebo effects in medicine and psychotherapy from randomized clinical trials.
    Wampold BE; Minami T; Tierney SC; Baskin TW; Bhati KS
    J Clin Psychol; 2005 Jul; 61(7):835-54. PubMed ID: 15827993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The evaluation of pharmacological drugs, medical devices, and non-pharmacological or public health interventions: Experimental design limitations. Moving towards new methods?].
    Villeval M; Carayol M; Lamy S; Lepage B; Lang T
    Rev Epidemiol Sante Publique; 2016 Dec; 64(6):381-389. PubMed ID: 27816308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The deception and fallacies of sponsored randomized prospective double-blinded clinical trials: the bisphosphonate research example.
    Marx RE
    Int J Oral Maxillofac Implants; 2014; 29(1):e37-44. PubMed ID: 24451886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating preference effects in partially unblinded, randomized clinical trials.
    Halpern SD
    J Clin Epidemiol; 2003 Feb; 56(2):109-15. PubMed ID: 12654404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A quantum-like model of homeopathy clinical trials: importance of in situ randomization and unblinding.
    Beauvais F
    Homeopathy; 2013 Apr; 102(2):106-13. PubMed ID: 23622260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applying evidence-based medicine to traditional chinese medicine: debate and strategy.
    Shea JL
    J Altern Complement Med; 2006 Apr; 12(3):255-63. PubMed ID: 16646724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials.
    Compalati E; Baena-Cagnani R; Penagos M; Badellino H; Braido F; Gómez RM; Canonica GW; Baena-Cagnani CE
    Int Arch Allergy Immunol; 2011; 156(1):1-15. PubMed ID: 21969990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.